首页> 外文OA文献 >PIN69 Economic Evaluation of Fidaxomicin for the Treatment of Clostridium Difficile Infections (CDI) also known as C. Difficile-Associated Diarrhoea (CDAD) in Ireland

【2h】

PIN69 Economic Evaluation of Fidaxomicin for the Treatment of Clostridium Difficile Infections (CDI) also known as C. Difficile-Associated Diarrhoea (CDAD) in Ireland

机译：PIN69经济评价非达索霉素用于治疗艰难梭菌感染（CDI）在爱尔兰也被称为C.难治性腹泻（CDAD）

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Van Engen A.; Casamayor M.; Loftus F.; Crimin E.; Lacey L.;
展开▼
作者单位

展开▼
年度 2013
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Fidaxomicin Versus Vancomycin as a First Line Treatment for C. difficile-Associated Diarrhea (CDAD) in Specific Patient Populations: A Pharmacoeconomic Evaluation [J] . Broderick Kelly, Xu Peng, Corvino Frank, The American Journal of Gastroenterology . 2014,第Suppla2期

机译：非达索霉素和万古霉素作为特定患者人群中艰难梭菌相关性腹泻（CDAD）的一线治疗：药物经济学评价
2. Surveillance of Clostridium difficile-associated diarrhoea with the German nosocomial infection surveillance system KISS (CDAD-KISS) [J] . P. Gastmeier, D. Weitzel-Kage, M. Behnke, International journal of antimicrobial agents . 2009,第s1期

机译：德国医院感染监测系统KISS（CDAD-KISS）对艰难梭菌相关性腹泻的监测
3. Economic assessment of fidaxomicin for the treatment of Clostridium difficile infection (CDI) in special populations (patients with cancer, concomitant antibiotic treatment or renal impairment) in Spain [J] . Rubio-Terres C., Cobo Reinoso J., Grau Cerrato S., European journal of clinical microbiology and infectious diseases: Official publication of the European Society of Clinical Microbiology . 2015,第11期

机译：非达索霉素在西班牙特殊人群（患有癌症，伴随抗生素治疗或肾功能不全的患者）治疗艰难梭菌感染的经济评估
4. Development of a Vaccine Against Clostridium difficile Infection (CDI): Design, Purification, and Biological Activities of the Recombinant Toxin 1 Antigens [C] . Jerzy Karczewski Vaccine technology IV . 2012

机译：针对艰难梭菌感染（CDI）疫苗的开发：重组毒素1抗原的设计，纯化和生物活性。
5. Prediction of Clostridium Difficile Infection Recurrence and Risk-Based Heterogeneity of Treatment Effect of Vnacomycin vs Fidaxomicin. [D] . Alraddadi, Basem. 2013

机译：瓦克霉素与非达霉素的难治性梭状芽胞杆菌感染复发的预测及基于风险的异质性。
6. 1952. Evaluation of Relapse and Reinfection Using Whole-Genome Sequencing of Clostridium difficile Isolates From Elderly Patients With C. difficile Infection (CDI) in the EXTEND Randomized Controlled Comparative Study of Extended-Pulsed Fidaxomicin and Vancomycin for the Treatment of CDI [O] . Mark Wilcox, Oliver A Cornely, Benoit Guery, -1

机译：1952年。在延长的非达索霉素和万古霉素对CDI治疗的EXTEND随机对照比较研究中对来自艰难梭菌感染老年患者（CDI）的艰难梭菌分离株进行全基因组测序评估复发和再感染
7. PIN60 Economic Evaluation of Fidaxomicin for the Treatment of Clostridium Difficile Infections (CDI) also Known as Clostridium Difficile-Associated Diarrhoea (CDAD) in Spain [O] . Cobo Reinoso J., Grau Cerrato S., Mensa Pueyo J., 2014

机译：非达索霉素用于治疗艰难梭菌感染（CDI）的PIN60经济评估在西班牙也称为艰难梭菌相关性腹泻（CDAD）
8. Evaluation and Research on Antimicrobial Stewardship's Effect on Clostridium difficile (ERASE C. difficile) Project. Toolkit for Reduction of Clostridium difficile through Antimicrobial Stewardship. [R] . 2012

机译：抗菌药物管理对艰难梭菌（ERasE C. difficile）项目影响的评价与研究。通过抗菌药物管理减少艰难梭菌的工具包。

PIN69 Economic Evaluation of Fidaxomicin for the Treatment of Clostridium Difficile Infections (CDI) also known as C. Difficile-Associated Diarrhoea (CDAD) in Ireland

著录项

引文网络

相似文献

相关主题

期刊订阅